YD Bio Ltd
NASDAQ:YDES
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
YD Bio Ltd
NASDAQ:YDES
|
TW |
|
Venture Life Group PLC
LSE:VLG
|
UK |
Multiples-Based Value
The Multiples-Based Value of one
YDES
stock under the Base Case scenario is
0.16
USD.
Compared to the current market price of 5.76 USD,
YD Bio Ltd
is
Overvalued by 97%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
YDES Competitors Multiples
YD Bio Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
|
YD Bio Ltd
NASDAQ:YDES
|
406.2m USD | 573.5 | -61.2 | -114.2 | -107.9 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
252.3B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
99.4B ZAR | 5.5 | 10.3 | 14.1 | 14.1 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
66.2B USD | 0 | 37 419 | -17 521.8 | -17 521.8 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.7B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
44.6B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
30.8B EUR | 1 | 169 | 30.8 | 64.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
32.8B USD | 13.6 | -2 982.6 | -3 927.2 | -631 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
29.2B ZAR | 5.5 | 6.7 | 17.3 | 17.3 |